New mRNA Vaccine Reduces Risk of Melanoma Recurrence by Over 40 Percent
Source:
wired
October 24, 2026 · 04:30
From the publisher
The vaccine is personalized to a patient’s tumor, and results from the Phase 3 trial are yet another example of the promise of mRNA vaccines in treating cancer.
About the source
Wired (magazine)
Wired is a bimonthly American magazine that examines the impact of emerging technologies on culture, the economy, and politics. It is published in both print and online editions by Condé Nast. The magazine has been in publication since its launch in January 1993. Its editorial office is based in San Francisco, California, with its business headquarters located in New York City.
Wikidata Q520154
Wikidata ↗
The original article opens on the publisher's website.
More from General
View topic →C.E.O.s Say the A.I. Rollout Is Going Well. Employees Feel Differently.
nytimes
Oct 24, 2026 · 05:00
The PHP Meltdown Shows How AI Makes Bugs More Exploitable
wired
Oct 24, 2026 · 05:00
U.S. Clarity Act failure gives Asia and Middle East a competitive edge, says Apex Group CEO
coinDesk
Oct 24, 2026 · 05:00
Gunmen open fire at a church during a funeral in Jordan, killing 7 and wounding 40
nprNews
Oct 24, 2026 · 04:59
Nvidia's role as AI financier faces first big test as neoclouds take market hit
cnbc
Oct 24, 2026 · 04:00